Your browser doesn't support javascript.
loading
Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patients.
van Wezel, Esther M; Decarolis, Boris; Stutterheim, Janine; Zappeij-Kannegieter, Lily; Berthold, Frank; Schumacher-Kuckelkorn, Roswitha; Simon, Thorsten; Fiocco, Marta; van Noesel, Max M; Caron, Huib N; van der Schoot, C Ellen; Hero, Barbara; Tytgat, Godelieve A M.
Afiliação
  • van Wezel EM; Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory of the AMC, University of Amsterdam, Amsterdam, The Netherlands; Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Center, University of Amsterdam, The Netherlands.
  • Decarolis B; Children's Hospital, University of Cologne, Pediatric Hematology and Oncology, Germany.
  • Stutterheim J; Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory of the AMC, University of Amsterdam, Amsterdam, The Netherlands; Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Center, University of Amsterdam, The Netherlands.
  • Zappeij-Kannegieter L; Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory of the AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Berthold F; Children's Hospital, University of Cologne, Pediatric Hematology and Oncology, Germany.
  • Schumacher-Kuckelkorn R; Children's Hospital, University of Cologne, Pediatric Hematology and Oncology, Germany.
  • Simon T; Children's Hospital, University of Cologne, Pediatric Hematology and Oncology, Germany.
  • Fiocco M; Department of Biostatistics, Leiden University Medical Center and Dutch Childhood Oncology Group, The Hague, The Netherlands.
  • van Noesel MM; Department of Pediatric Oncology, Sophia Children's Hospital, Erasmus Medical Center, Rotterdam, The Netherlands; Prinses Máxima Centrum, Utrecht, The Netherlands.
  • Caron HN; Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Center, University of Amsterdam, The Netherlands.
  • van der Schoot CE; Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory of the AMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Hero B; Children's Hospital, University of Cologne, Pediatric Hematology and Oncology, Germany.
  • Tytgat GAM; Department of Pediatric Oncology, Emma Children's Hospital, Academic Medical Center, University of Amsterdam, The Netherlands; Prinses Máxima Centrum, Utrecht, The Netherlands. Electronic address: g.a.tytgat@amc.uva.nl.
Eur J Cancer ; 54: 149-158, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26796600

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medula Óssea / RNA Mensageiro / RNA Neoplásico / Biomarcadores Tumorais / Neuroblastoma Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medula Óssea / RNA Mensageiro / RNA Neoplásico / Biomarcadores Tumorais / Neuroblastoma Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2016 Tipo de documento: Article